A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer

Prostate cancer (PCa) is a common malignancy that poses a major threat to the health of men. Prostate-specific antigen (PSA) and its derivatives, as FDA-approved detection assays, are insufficient to serve as optimal markers for patient prognosis and clinical decision-making. It is widely acknowledg...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Tao, Wang, Jian, Yan, Shi, Meng, Xiangyu, Zhang, Xiaomin, Xu, Shuang, Ren, Shancheng, Huang, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634133/
https://www.ncbi.nlm.nih.gov/pubmed/36339430
http://dx.doi.org/10.3389/fendo.2022.1037099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634133/
https://www.ncbi.nlm.nih.gov/pubmed/36339430
http://dx.doi.org/10.3389/fendo.2022.1037099

Ejemplares similares